Open access
Aug 2026
Second-line chemotherapy efficacy is not affected by prior exposure to immunotherapy in extensive-disease small-cell lung cancer: results from the ESME French national real-world cohort
This study showed no OS gain in second-line treatment among patients pretreated with immunotherapy compared with those who received chemotherapy alone as first-line treatment.
E. Gobbini, M. H. Diallo, C. Clément-Duchêne et al.
· ESMO Open · 0 citations